维普中文期刊产品整合服务
22篇 您的检索式:作者名="Masonson"
    题名 作者 年代 出处 被引量
1Pharmacokinetics of CS-866,a new angiotensin Ⅱ receptor blocker,in healthy subjects显示文摘Schwocho LR Masonson HN 2001J Clin Pharmacol2001,41,5:1
2Pharmacokinetics of CS-866, a new angiotensin Ⅱ receptor blocker, in healthy subjects显示文摘Sehwocho LR Masonson HN 2001J Clin Pharmacol2001,41,5:1
3Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials 显示文摘D' Amico DJ Masonson HN Patel M Adamis AP Cunningham ET Jr Guyer DR VEGF Inhibition Study in Ocular Neovascularization (VISION)Clhfical Trial Group 2006Ophthalmology2006,113,6:1
4Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial显示文摘Singerman LJ Masonson H Patel M Adamis AP Buggage R Cunningham E 2008Br J Ophthalmol2008,92,12:1
5Pharmacokinetics of CS-866, a new angiotension Ⅱ receptor blocker,in health subjects 显示文摘Schwocho LR Masonson HN 2001J Clin Pharmacol2001,41,5:1
6Pharmacokinetics of CS-866,a new angiotensin Ⅱ receptor blocker,in healthy subjects显示文摘SCHWOCHO LR MASONSON HN 2001Clin Pharmacol2001,41,5:1
7Pharmacokinetics of CS-866, a new angiotensin Ⅱ receptor blocker, in health subjects显示文摘SCHWOCHO LR MASONSON HN 2001J Clin Pharmacol2001,41,5:1
8Pegaptanib sodium for neovascular age - related macular degeneration : two - year safety results of the two prospective, multicenter, controlled clinical trials显示文摘D' AMICO D J MASONSON H N PATEL M 2006Ophthalmology2006,113,:1
9Pegaptanib sodium for neovascular age-related macular degeneration:third-year safety results of VEGF Inhibition Study in Ocular Neovascularisation(VISION)trial显示文摘Singerman LJ Masonson H Patel M 0,,:1
10Pharmacokinetics of CS- 866,a new angiotensin I1 receptor blocker,in healthy subjects显示文摘Schwocho LR Masonson HN 2001J Clin Pharmacol2001,41,5:1
11Pegaptanib sodium for neovascular age-related macular degeneration: Two-year safety results of the two prospective, multicenter, controlled clinical trials显示文摘D'Amico DJ Masonson HN Patel M 2006Ophthalmology2006,113,6:1
12Pharmacokinetics of CS-866,a new angiotensin Ⅱ receptor blocker,in healthy subjects显示文摘SCHWOCHO L R MASONSON H N 2001J Clin Phamacol2001,41,5:1
13Pegaptanib sodium for neovascular age-related macular degeneration-Two-year safety results of the two prospective, multicenter, controlled clinical trials显示文摘D'AMICO DJ MASONSON HN PATEL M 2006Ophthalmology2006,113,6:1
14Pegaptanib sodium for neovascular age-related macular degeneration:third-year safety re-sults of the VEGF Inhibition Study in Ocular Neovascularisation(VISION)trial显示文摘Singerman LJ Masonson H Patel M 2008Br J Ophthalmol2008,92,12:1
15Pharmacokinetics of CS - 866, a new angiotensin Ⅱ receptor blocker, in healthy subjects 显示文摘Schwocho LR Masonson HN 2001J Clin Pharmacol2001,41,:1
16Pegaptanib sodium for neovascular age-related macular degeneration : two-year safety results of the two prospective, multicenter, controlled clini- cal trials 显示文摘D'AMICO DJ MASONSON HN PATEL M 2006Ophthalmology2006,113,6:1
17Pharmacokinetics of CS-866,a new angiotensin II receptor blocker,in healthy subjects显示文摘Schwocho L R Masonson H N 2001J Clin Pharmacol2001,41,5:1
18Pharmacokinetics of CS - 866, a new angiotensin Ⅱ receptor blocker, in healthy subjects显示文摘Schwocho LR Masonson HN 2001J Clin Pharmacol2001,41,5:1
19Pegaptanib sodium for neovascular age-related macular degeneration: Third-year safety results of the VEGF inhibition study in ocular neovascularisation (VISION) trial 显示文摘Singerman L J Masonson H Pate1 M 2008Br J Ophthalmol2008,92,12:1
20Pegaptanib sodium for neovascular age-related macular degeneration:two- year safety results of the two prospective, multicenter, controlled clinical trials显示文摘D' Amico DJ Masonson HN Patel M 2006Ophthalmology2006,113,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费